| Dr Eugene Collins, MD | |
|
1333 West Lombard Street, Davenport, IA 52804-2193 | |
| (563) 322-6666 | |
| (563) 322-6844 |
| Full Name | Dr Eugene Collins |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 1333 West Lombard Street, Davenport, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285697003 | NPI | - | NPPES |
| 0161323 | Medicaid | IA | |
| 0091204066 | Other | IL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 21720 (Iowa) | Primary |
| 207T00000X | Neurological Surgery | (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eugene Collins, MD 1333 West Lombard Street, Davenport, IA 52804-2193 Ph: (563) 322-6666 | Dr Eugene Collins, MD 1333 West Lombard Street, Davenport, IA 52804-2193 Ph: (563) 322-6666 |
News Archive
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that they have entered into a Biopharmaceutical Development and Manufacturing Agreement.
Elsevier (http://www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of NurseSquared (http://www.nursesquared.com) , the leading electronic health record (EHR) training product in the market that teaches students how to properly document using a simulated EHR. The NurseSquared training tool allows Elsevier to offer a more complete curriculum solution, including an EHR training tool, to academic customers.
Pay-for-performance-reimbursing health care providers based on the results they achieved with their patients as a way to improve quality and efficiency-has become a major component of health reforms in the United States, the United Kingdom, and other affluent countries. Although the approach has also become popular in the developing world, there has been little evaluation of its impact.
A new clinical resource from the American Association of Critical-Care Nurses (AACN) provides one-stop convenience for nurses, clinicians and other healthcare professionals seeking evidence-based knowledge and tools to help them improve patient outcomes.
Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that the Instituto de Salud Publica of Chile has approved the Company's protocol for its Phase 2 clinical study of TI-001, intranasal oxytocin, for the treatment of chronic migraine.
› Verified 1 days ago
Todd Ridenour, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1230 E Rusholme St Ste 303, Davenport, IA 52803 Phone: 563-383-2763 Fax: 563-328-5500 |